Alternative Medications to Tramadol for Moderate to Moderately Severe Pain

Primary Alternative: Tapentadol

The National Comprehensive Cancer Network recommends tapentadol as the preferred first-line alternative to tramadol, offering superior gastrointestinal tolerability with comparable or better analgesic efficacy 1, 2
Tapentadol has a similar dual mechanism of action to tramadol, but with superior efficacy and tolerability, making it a suitable replacement for patients requiring an opioid alternative 1, 2
The starting dose of tapentadol is 50-100 mg orally every 4-6 hours as needed, with a maximum daily dose of 600 mg/day for immediate-release formulation and 500 mg/day for extended-release formulation 1
Tapentadol has significantly fewer gastrointestinal adverse effects compared to traditional opioids like oxycodone, and it has demonstrated efficacy in both nociceptive and neuropathic pain 1

The American Cancer Society and the National Comprehensive Cancer Network suggest that morphine is the opioid of first choice for moderate to severe cancer pain, and it remains the WHO essential drug list standard 2
Oral morphine is approximately 10 times more potent than tramadol, and it is recommended to use low-dose morphine (≤60 mg/day) as an alternative to high-dose tramadol (≥300 mg/day) 1, 2, 3
Hydrocodone and codeine have demonstrated better tolerability than tramadol in direct comparison studies, with codeine dosing at 15-60 mg every 4-6 hours, maximum 360 mg/day 2, 5

The American Pain Society recommends maximizing non-opioid analgesics before or alongside weak opioids, with acetaminophen up to 4000 mg/day in divided doses and ibuprofen 600 mg every 6 hours (maximum 2400 mg/day) 2

The National Comprehensive Cancer Network advises avoiding concurrent SSRI, SNRI, TCA, or MAOI use with both tramadol and tapentadol due to serotonin syndrome risk 1, 3, 4

The American Geriatrics Society recommends reducing the maximum daily dose of tramadol to 300 mg/day in elderly patients (≥75 years), and starting tapentadol at the lower end of the dosing range (50 mg) 5, 4
The National Kidney Foundation suggests that buprenorphine is the preferred opioid option for patients with renal impairment due to its favorable pharmacokinetics 1

If a patient is on serotonergic medications, avoid both tramadol and tapentadol, and choose low-dose morphine, hydrocodone, codeine, or dihydrocodeine instead 1, 3, 4
If a patient has normal hepatic/renal function and is not on serotonergic drugs, tapentadol 50-100 mg every 4-6 hours is the first choice 1, 3
If a patient has renal impairment, transdermal buprenorphine 5 mcg/hour is the first choice 1
If a patient is elderly (≥75 years), levorphanol is a simpler alternative to methadone, and tapentadol can be used at a reduced starting dose 1, 3, 5